OncoImmune

Merck takes $170M charge on abandoned COVID-19 drug
Fierce Biotech
Thu, 05/6/21 - 10:59 am
Merck
OncoImmune
COVID-19
Merck cans one COVID-19 drug, scraps a clinical trial of another
Fierce Biotech
Thu, 04/15/21 - 10:36 am
Merck
COVID-19
MK-7110
OncoImmune
clinical trials
Merck's OncoImmune COVID-19 Therapeutic Stuck at Starting Gate Pending Further Data
BioSpace
Sun, 02/28/21 - 10:16 pm
Merck
COVID-19
OncoImmune
M&A
FDA
[video+transcript]Here's Why Biotech Deals Are All the Rage Right Now
Motley Fool
Sat, 12/5/20 - 11:24 pm
biotech
M&A
Biogen
SAGE Therapeutics
Eli Lilly
Precision Biosciences
Merck
OncoImmune
Merck to acquire Oncolmmune, accelerating development of COVID-19 treatment candidate
Biopharma Reporter
Mon, 11/23/20 - 10:43 am
Merck
OncoImmune
M&A
CD24Fc
COVID-19
OncoImmune nabs $56M round for late-stage COVID-19 tests, leukemia treatment
Fierce Biotech
Wed, 09/9/20 - 10:57 am
OncoImmune
COVID-19
leukemia
CD24Fc
OncoImmune receives FDA approval for COVID-19 clinical trial
Pharmaceutical Business Review
Thu, 04/9/20 - 10:29 am
OncoImmune
FDA
clincial trials
CD24Fc
COVID-19
Pfizer's Latest Immunotherapy Deal Could Be Great News for This Tiny Company
Motley Fool
Tue, 09/27/16 - 09:53 am
Pfizer
Agenus
OncoImmune